NCT01346020进行中(未招募)不适用
Genomic Analysis of Patients With Chronic Lymphocytic Leukemia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 入组人数
- 53
- 试验地点
- 1
- 主要终点
- Time to therapy
研究概览
简要总结
This study aims to characterize clonal evolution in chronic lymphocytic leukemia (CLL) using different approaches and to identify a possible association with disease progression, i.e. therapy initiation.
- Samples This monocentric study is carried out using representative bioarchived leukemic samples with a diagnosis of CLL, either at diagnosis or at evolution. These bioarchived samples were collected locally at our center during years of diagnostic activity, and were accurately pathologically, cytogenetically and molecularly characterized.
- Clinical data The clinical data were retrospectively collected through collaboration with the referring physicians.
- Methods Samples will be investigated by means of (1) conventional cytogenetics, (2) fluorescence in situ hybridization (FISH) and (3) SNP-arrays. After analysis of the array data sets, significant results will be validated and in addition, results will be correlated with clinical data.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 0 Years 至 130 Years(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •diagnosis of CLL,
- •at least two available stored samples
排除标准
- •at least one inclusion criterium not fulfilled
结局指标
主要结局
Time to therapy
时间窗: baseline to day 1 of therapy
Time from diagnosis to the start of first line therapy
次要结局
- Genetic abnormalities detected by karyotyping, FISH or array-analysis(13-102 months)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Understanding Chronic Lymphocytic LeukemiaChronic Lymphocytic LeukemiaNCT04028531Dana-Farber Cancer Institute2,750
Unknown
不适用
Genetic Study of Chronic Lymphocytic Leukemia FamiliesLeukemiaNCT00503256M.D. Anderson Cancer Center4,000
进行中(未招募)
不适用
A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in GreeceChronic Lymphocytic LeukemiaNCT04159779AbbVie180
进行中(未招募)
1 期
Therapy with ibrutinib for patients with Chronic lymphocytic leukemia with subclonal TP53 aberrationsCTIS2024-514823-41-00Ospedale San Raffaele S.r.l.120
招募中
2 期
Therapy with ibrutinib for patients with Chronic lymphocytic leukemia with subclonal TP53 aberrations2024-514823-41-00Ospedale San Raffaele S.r.l.120
